The US FDA’s hybrid work policy may be in danger now that the White House wants federal employees working in the office more often.
White House Chief of Staff Jeff Zients sent a memo to cabinet members asking them to aggressively work to increase...
The CBER director has worried that ‘someone’ might try to end the US FDA’s hybrid work policy. Now the push against it is bipartisan.

The US FDA’s hybrid work policy may be in danger now that the White House wants federal employees working in the office more often.
White House Chief of Staff Jeff Zients sent a memo to cabinet members asking them to aggressively work to increase...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.